Unknown

Dataset Information

0

Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.


ABSTRACT: About a third of tumors have activating mutations in HRAS, NRAS, or KRAS, genes encoding guanosine triphosphatases (GTPases) of the RAS family. In these tumors, wild-type RAS cooperates with mutant RAS to promote downstream effector activation and cell proliferation and transformation, suggesting that upstream activators of wild-type RAS are important modulators of mutant RAS-driven oncogenesis. The guanine nucleotide exchange factor (GEF) SOS1 mediates KRAS-driven proliferation, but little is understood about the role of SOS2. We found that RAS family members have a hierarchical requirement for the expression and activity of SOS2 to drive cellular transformation. In mouse embryonic fibroblasts (MEFs), SOS2 critically mediated mutant KRAS-driven, but not HRAS-driven, transformation. Sos2 deletion reduced epidermal growth factor (EGF)-dependent activation of wild-type HRAS and phosphorylation of the kinase AKT in cells expressing mutant RAS isoforms. Assays using pharmacological inhibitors revealed a hierarchical requirement for signaling by phosphoinositide 3-kinase (PI3K) in promoting RAS-driven cellular transformation that mirrored the requirement for SOS2. KRAS-driven transformation required the GEF activity of SOS2 and was restored in Sos2-/- MEFs by expression of constitutively activated PI3K. Finally, CRISPR/Cas9-mediated deletion of SOS2 reduced EGF-stimulated AKT phosphorylation and synergized with MEK inhibition to revert the transformed phenotype of human KRAS mutant pancreatic and lung tumor cells. These results indicate that SOS2-dependent PI3K signaling mediates mutant KRAS-driven transformation, revealing therapeutic targets in KRAS-driven cancers. Our data also reveal the importance of three-dimensional culture systems in investigating the mediators of mutant KRAS.

SUBMITTER: Sheffels E 

PROVIDER: S-EPMC7396125 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.

Sheffels Erin E   Sealover Nancy E NE   Wang Chenyue C   Kim Do Hyung DH   Vazirani Isabella A IA   Lee Elizabeth E   M Terrell Elizabeth E   Morrison Deborah K DK   Luo Ji J   Kortum Robert L RL  

Science signaling 20180904 546


About a third of tumors have activating mutations in <i>HRAS</i>, <i>NRAS</i>, or <i>KRAS</i>, genes encoding guanosine triphosphatases (GTPases) of the RAS family. In these tumors, wild-type RAS cooperates with mutant RAS to promote downstream effector activation and cell proliferation and transformation, suggesting that upstream activators of wild-type RAS are important modulators of mutant RAS-driven oncogenesis. The guanine nucleotide exchange factor (GEF) SOS1 mediates KRAS-driven prolifera  ...[more]

Similar Datasets

| S-EPMC86116 | biostudies-literature
| S-EPMC3690838 | biostudies-literature
| S-EPMC305602 | biostudies-literature
2010-06-10 | E-GEOD-6194 | biostudies-arrayexpress
2006-10-30 | GSE6194 | GEO
| S-EPMC6071550 | biostudies-literature
| S-EPMC2670128 | biostudies-literature
| S-EPMC6702192 | biostudies-literature
| S-EPMC231864 | biostudies-other
| S-EPMC8342309 | biostudies-literature